319 related articles for article (PubMed ID: 34817788)
1. Thrombosis in VEXAS syndrome.
Oo TM; Koay JTJ; Lee SF; Lee SMS; Lim XR; Fan BE
J Thromb Thrombolysis; 2022 May; 53(4):965-970. PubMed ID: 34817788
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic manifestations of VEXAS syndrome.
Groarke EM; Dulau-Florea AE; Kanthi Y
Semin Hematol; 2021 Oct; 58(4):230-238. PubMed ID: 34802545
[TBL] [Abstract][Full Text] [Related]
3. Venous and arterial thrombosis in patients with VEXAS syndrome.
Kusne Y; Ghorbanzadeh A; Dulau-Florea A; Shalhoub R; Alcedo PE; Nghiem K; Ferrada MA; Hines A; Quinn KA; Panicker SR; Ombrello AK; Reichard K; Darden I; Goodspeed W; Durrani J; Wilson L; Olteanu H; Lasho T; Kastner DL; Warrington KJ; Mangaonkar A; Go RS; Braylan RC; Beck DB; Patnaik MM; Young NS; Calvo KR; Casanegra AI; Grayson PC; Koster MJ; Wu CO; Kanthi Y; Patel BA; Houghton DE; Groarke EM
Blood; 2024 May; 143(21):2190-2200. PubMed ID: 38306657
[TBL] [Abstract][Full Text] [Related]
4. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS.
Ferrada MA; Sikora KA; Luo Y; Wells KV; Patel B; Groarke EM; Ospina Cardona D; Rominger E; Hoffmann P; Le MT; Deng Z; Quinn KA; Rose E; Tsai WL; Wigerblad G; Goodspeed W; Jones A; Wilson L; Schnappauf O; Laird RS; Kim J; Allen C; Sirajuddin A; Chen M; Gadina M; Calvo KR; Kaplan MJ; Colbert RA; Aksentijevich I; Young NS; Savic S; Kastner DL; Ombrello AK; Beck DB; Grayson PC
Arthritis Rheumatol; 2021 Oct; 73(10):1886-1895. PubMed ID: 33779074
[TBL] [Abstract][Full Text] [Related]
5. UBA1 and DNMT3A mutations in VEXAS syndrome. A case report and literature review.
Shaukat F; Hart M; Burns T; Bansal P
Mod Rheumatol Case Rep; 2022 Jan; 6(1):134-139. PubMed ID: 34480172
[TBL] [Abstract][Full Text] [Related]
6. VEXAS syndrome in dermatology.
Afsahi V; Christensen RE; Alam M
Arch Dermatol Res; 2023 Mar; 315(2):161-164. PubMed ID: 35201420
[TBL] [Abstract][Full Text] [Related]
7. Case report: Cerebral sinus vein thrombosis in VEXAS syndrome.
Zisapel M; Seyman E; Molad J; Hallevi H; Mauda-Havakuk M; Jonas-Kimchi T; Elkayam O; Eviatar T
Front Med (Lausanne); 2024; 11():1377768. PubMed ID: 38651063
[TBL] [Abstract][Full Text] [Related]
8. Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome.
Patel N; Dulau-Florea A; Calvo KR
Semin Hematol; 2021 Oct; 58(4):204-211. PubMed ID: 34802541
[TBL] [Abstract][Full Text] [Related]
9. Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.
Beck DB; Bodian DL; Shah V; Mirshahi UL; Kim J; Ding Y; Magaziner SJ; Strande NT; Cantor A; Haley JS; Cook A; Hill W; Schwartz AL; Grayson PC; Ferrada MA; Kastner DL; Carey DJ; Stewart DR
JAMA; 2023 Jan; 329(4):318-324. PubMed ID: 36692560
[TBL] [Abstract][Full Text] [Related]
10. Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS.
van der Made CI; Potjewijd J; Hoogstins A; Willems HPJ; Kwakernaak AJ; de Sevaux RGL; van Daele PLA; Simons A; Heijstek M; Beck DB; Netea MG; van Paassen P; Elizabeth Hak A; van der Veken LT; van Gijn ME; Hoischen A; van de Veerdonk FL; Leavis HL; Rutgers A
J Allergy Clin Immunol; 2022 Jan; 149(1):432-439.e4. PubMed ID: 34048852
[TBL] [Abstract][Full Text] [Related]
11. VEXAS syndrome: lessons learnt from an early Australian case series.
Islam S; Cullen T; Sumpton D; Damodaran A; Heath D; Bosco A; Doo NW; Kidson-Gerber G; Cheong A; Lawford R; Walsh R; Sammel A
Intern Med J; 2022 Apr; 52(4):658-662. PubMed ID: 35419965
[TBL] [Abstract][Full Text] [Related]
12. VEXAS within the spectrum of rheumatologic disease.
Koster MJ; Warrington KJ
Semin Hematol; 2021 Oct; 58(4):218-225. PubMed ID: 34802543
[TBL] [Abstract][Full Text] [Related]
13. How I diagnose and manage VEXAS syndrome.
Hagiya A; Siddiqi IN; Wang E; Lu CM
Am J Clin Pathol; 2024 Jul; 162(1):28-40. PubMed ID: 38511841
[TBL] [Abstract][Full Text] [Related]
14. Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis.
Ferrada MA; Savic S; Cardona DO; Collins JC; Alessi H; Gutierrez-Rodrigues F; Kumar DBU; Wilson L; Goodspeed W; Topilow JS; Paik JJ; Poulter JA; Kermani TA; Koster MJ; Warrington KJ; Cargo C; Tattersall RS; Duncan CJA; Cantor A; Hoffmann P; Payne EM; Bonnekoh H; Krause K; Cowen EW; Calvo KR; Patel BA; Ombrello AK; Kastner DL; Young NS; Werner A; Grayson PC; Beck DB
Blood; 2022 Sep; 140(13):1496-1506. PubMed ID: 35793467
[TBL] [Abstract][Full Text] [Related]
15. Case Report: VEXAS Syndrome: From Mild Symptoms to Life-Threatening Macrophage Activation Syndrome.
Staels F; Betrains A; Woei-A-Jin FJSH; Boeckx N; Beckers M; Bervoets A; Willemsen M; Neerinckx B; Humblet-Baron S; Blockmans DE; Vanderschueren S; Schrijvers R
Front Immunol; 2021; 12():678927. PubMed ID: 34046042
[TBL] [Abstract][Full Text] [Related]
16. Recurrent orbital inflammation associated with VEXAS syndrome.
Beecher MB; Tong JY; Halliday LA; Hissaria P; Selva D
Orbit; 2024 Jun; 43(3):350-353. PubMed ID: 36168114
[TBL] [Abstract][Full Text] [Related]
17. Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients.
Georgin-Lavialle S; Terrier B; Guedon AF; Heiblig M; Comont T; Lazaro E; Lacombe V; Terriou L; Ardois S; Bouaziz JD; Mathian A; Le Guenno G; Aouba A; Outh R; Meyer A; Roux-Sauvat M; Ebbo M; Zhao LP; Bigot A; Jamilloux Y; Guillotin V; Flamarion E; Henneton P; Vial G; Jachiet V; Rossignol J; Vinzio S; Weitten T; Vinit J; Deligny C; Humbert S; Samson M; Magy-Bertrand N; Moulinet T; Bourguiba R; Hanslik T; Bachmeyer C; Sebert M; Kostine M; Bienvenu B; Biscay P; Liozon E; Sailler L; Chasset F; Audemard-Verger A; Duroyon E; Sarrabay G; Borlot F; Dieval C; Cluzeau T; Marianetti P; Lobbes H; Boursier G; Gerfaud-Valentin M; Jeannel J; Servettaz A; Audia S; Larue M; Henriot B; Faucher B; Graveleau J; de Sainte Marie B; Galland J; Bouillet L; Arnaud C; Ades L; Carrat F; Hirsch P; Fenaux P; Fain O; Sujobert P; Kosmider O; Mekinian A; ;
Br J Dermatol; 2022 Mar; 186(3):564-574. PubMed ID: 34632574
[TBL] [Abstract][Full Text] [Related]
18. Clinical Challenges of Emerging Acquired Autoinflammatory Diseases, Including VEXAS Syndrome.
Kirino Y
Intern Med; 2024 Feb; ():. PubMed ID: 38296470
[TBL] [Abstract][Full Text] [Related]
19. The VEXAS Syndrome: Uncontrolled Inflammation and Macrocytic Anaemia in a 77-Year-Old Male Patient.
Himmelmann A; Brücker R
Eur J Case Rep Intern Med; 2021; 8(4):002484. PubMed ID: 33987129
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and genetic features of MDS associated with VEXAS syndrome].
Kunimoto H
Rinsho Ketsueki; 2024; 65(4):255-264. PubMed ID: 38684436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]